1Li YX,Coucke PA,Li JY,et al.Primary non-Hodgkin' s lymphoma of the nasal cavity:Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy[J].Cancer,1998,83(3):449-456.
2Kim WS,Song SY,Ahn YC,et al.CHOP followed by involved field radiation:is it optimal for localized nasal natural killer/T-cell lymphoma[J].Ann Oncol,2001,12(3):349-352.
3Li T,Hongyo T,Syaifudin M,et al.Mutations of the p.53 gene in nasal NK/T-cell lymphoma[J].Lab Invest,2000,80(4):493-499.
4Cheng AL,Su IJ,Chan YC,et al.Characteristic clinicopathologic features of epstein-barr virus-associated peripheral T-cell lymphoma[J].Cancer,1993,72(3):909-916.
5Chim CS,Ma SY,Au WY,et al.Primary nasal natural killer cell lymphoma:long-term treatment outcome and relationship with the international prognostic index[J].Blood,2004,103(1):216-221.
6Cheung MMC,Chan JKC,Lou KC,et al.Primary non-Hodgkin' s lymphoma of nose and nasopharynx:clinical features,tumor immunophenotype,and treatment outcome in 113 patients[J].Clinocol,1998,16(1):70277.
7Wang B,Lu J J,Ma X,et al.Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity[J].Leuk Lymphoma,2007,48(2):396-402.
9Chang ST,Lu CL,Chuang SS.CD《,52》 expression in non-mycoticT-and NK/T-cell lymphomas[J].Leuk Lymphoma,2007,48(1):117-121.
10Lee J,Sub C,Park YH,et al.Ext ranodal Natural Killer T-Cell Lymphoma,Nasal-Type:a prognosis model from a ret rospective multicenter study[J].J Clin Oncol,2006,24(4):612-618.
5Li YX,Coueke PA,Li JY,et al.Primary non-Hodghin's lymphoma of the nasal cavity:prognostic significance of para-nasal extension and the role of radiotherapy and ehemotherapy[J].Caneer,1998,83(5):449-456.
6Li T,Hongyo T,Syaifudin M,et al.Mutations of the p53 gene in nasal NK/T-cell ymphoma[J].Lab Invest,2000,80(4):493-499.
